ExScale Bio Overview

  • Founded
  • 2012
Founded
  • Status
  • Acquired/​Merged
  • Employees
  • 4
Employees
  • Latest Deal Type
  • M&A

ExScale Bio General Information

Description

Provider of laboratory services intended to offer large-scale nucleic acid extraction from human tissue samples. The company's services provides automated, next generation technology for nucleic acid extraction from formalin-fixed, paraffin-embedded (FFPE) tissue sections using paramagnetic beads, enabling clinicians to do serial extraction of DNA and RNA from the same biospecimen where the isolated nucleic acids are of optimal quality for next generation sequencing and other downstream applications.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Formerly Angel backed
Primary Industry
Laboratory Services (Healthcare)
Other Industries
Other Pharmaceuticals and Biotechnology
Primary Office
  • Dag Hammarskjöldsväg 26
  • Majoren, Uppsala Science Park
  • 752 37 Uppsala
  • Sweden
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

ExScale Bio Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Merger/Acquisition 29-Oct-2019 Completed Generating Revenue
1. Early Stage VC Completed Startup
To view ExScale Bio’s complete valuation and funding history, request access »

ExScale Bio Patents

ExScale Bio Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20180148713-A1 Deparaffinization of ffpe tissue samples Granted 25-Nov-2016 00000000
US-10274405-B2 Deparaffinization of ffpe tissue samples Active 25-Nov-2016 00000000 0
ES-2665012-T3 Procedure and kit for sequential isolation of nucleotide species from a sample Active 29-Jun-2010 00000000000
US-20130164819-A1 Method and kit for sequential isolation of nucleotide species from a sample Granted 29-Jun-2010 00000000000 0
US-8889393-B2 Method and kit for sequential isolation of nucleotide species from a sample Active 29-Jun-2010 C12N15/1006 0
To view ExScale Bio’s complete patent history, request access »

ExScale Bio Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

ExScale Bio Former Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Almi Invest Venture Capital Minority 000 0000 000000 0
To view ExScale Bio’s complete investors history, request access »